江苏天晟药业股份有限公司
这是描述信息

Jining Shengtai Pharmaceutical Co., Ltd

About Us

Located in the provincial chemical park-Jining New Material Industrial Park, the factory covers an area of 200 acres

One of the Key construction projects of Shandong Province

With a number of FDA and GMP standard production workshops, mainly engaged in the R&D and production of characteristic APIs such as anti-tumor, hypolipidemic, and cardiovascular health drugs; Entrusted R&D and production of high-end pharmaceutical intermediates and APIs

About Us

Located in the provincial chemical park-Jining New Material Industrial Park, the factory covers an area of 200 acres.One of the Key construction projects of Shandong Province.With a number of FDA and GMP standard production workshops, mainly engaged in the R&D and production of characteristic APIs such as anti-tumor, hypolipidemic, and cardiovascular health drugs; Entrusted R&D and production of high-end pharmaceutical intermediates and APIs

江苏天晟药业股份有限公司

As the synthetic API production base of Tiansheng pharmaceutical, the core competitive advantages of Jining Shengtai pharmaceutical are product quality in line with international standards, perfect EHS system and green and environmental friendly chemical manufacturing concept. The company has production equipment and systems ranging from kilogram level to ton level with cryogenic, high-pressure hydrogenation and high-temperature reaction types. Through the accumulation of core technologies in photochemistry, enzyme catalysis, fluid and micro reaction, asymmetric catalytic hydrogenation and other aspects, the company has achieved the advantages of leading synthesis technology, cost and stable supply capacity, and has been certified with a strict quality management system in line with international standards Quality standards and advanced quality control means provide high-quality pharmaceutical intermediates and characteristic API services to customers at home and abroad.

江苏天晟药业股份有限公司

As the synthetic API production base of Tiansheng pharmaceutical, the core competitive advantages of Jining Shengtai pharmaceutical are product quality in line with international standards, perfect EHS system and green and environmental friendly chemical manufacturing concept. The company has production equipment and systems ranging from kilogram level to ton level with cryogenic, high-pressure hydrogenation and high-temperature reaction types. Through the accumulation of core technologies in photochemistry, enzyme catalysis, fluid and micro reaction, asymmetric catalytic hydrogenation and other aspects, the company has achieved the advantages of leading synthesis technology, cost and stable supply capacity, and has been certified with a strict quality management system in line with international standards Quality standards and advanced quality control means provide high-quality pharmaceutical intermediates and characteristic API services to customers at home and abroad.

The company has formed cooperation with many domestic well-known enterprises, and the service content covers one-stop service from preclinical pharmaceutical research of new drugs, process R & D and trial production of APIs in clinical and various stages to industrialized production; The main product types cover the treatment fields of liver diseases, cardiovascular diseases, anti-tumor and other diseases; At the same time, it can provide first-class and comprehensive entrusted R & D and customized production services for global multinational pharmaceutical enterprises and new drug research and innovation companies.

 

The main construction of phase I production workshop, public works center and science and technology R & D building of the project has been completed and entered the decoration stage. It will be put into production in the second half of 2022. It is estimated that the operating revenue will exceed 500 million yuan within five years after reaching the production capacity.

江苏天晟药业股份有限公司
江苏天晟药业股份有限公司

The company has formed cooperation with many domestic well-known enterprises, and the service content covers one-stop service from preclinical pharmaceutical research of new drugs, process R & D and trial production of APIs in clinical and various stages to industrialized production; The main product types cover the treatment fields of liver diseases, cardiovascular diseases, anti-tumor and other diseases; At the same time, it can provide first-class and comprehensive entrusted R & D and customized production services for global multinational pharmaceutical enterprises and new drug research and innovation companies.

 

The main construction of phase I production workshop, public works center and science and technology R & D building of the project has been completed and entered the decoration stage. It will be put into production in the second half of 2022. It is estimated that the operating revenue will exceed 500 million yuan within five years after reaching the production capacity.

江苏天晟药业股份有限公司

WeChat

江苏天晟药业股份有限公司

©2022 JIANGSU TIANSHENG PHARMACEUTICAL CO.,LTD.  苏ICP备14003387号

Powered by:300.cn  SEO